This application claims the priority filing benefit of International PCT Application PCT/GB2012/052783 filed Nov. 8, 2012 and published under PCT 21(2) in the English language and Great Britain Patent Application Serial No. 1119420.6 filed Nov. 10, 2011. All of the above listed applications are herein incorporated by reference.
The present invention relates to perfusion systems for bodily organs, for example human organs, such as the liver, pancreas, kidney, small bowel, but also other organs including non-human organs. In particular the invention relates to the supply of oxygen for such systems and the control of the content of perfusion fluids in such systems.
It is known, for example from EP 1 168 913, to provide a system for extracorporeal organ perfusion in which a human or non-human organ can be preserved, for example prior to transplant into a patient. The system typically comprises a reservoir for perfusion fluid (or perfusate), which may be blood or another perfusion solution, and a circuit for circulating the fluid through the organ. The circuit typically also comprises an oxygenator or other device for adding oxygen, carbon dioxide, or other substances into the blood, from a source which typically comprises a pressurized gas cylinder.
The present invention provides a perfusion system for the perfusion of an organ, the system comprising a fluid circuit for connection to the organ and arranged to supply perfusion fluid (perfusate) to the organ, and oxygenation means arranged to add oxygen into the fluid as the fluid circulates in the circuit, and an oxygen supply arranged to supply oxygen to the oxygenation means.
The oxygen supply may comprise an oxygen concentrator. The oxygen concentrator may have an inlet arranged to receive air, which may be at atmospheric pressure. The oxygen concentrator may comprise nitrogen extraction means for extracting nitrogen from the air. The oxygen concentrator may comprise an outlet from which gas can be fed to the oxygenator.
The system may further comprise an air supply arranged to supply air to the oxygenation means whereby the oxygenation means can add carbon dioxide to the perfusion fluid.
The oxygen concentrator may comprise a compressor arranged to pump the gas through the nitrogen extraction means. The pump may be arranged to pump gas to the oxygenation means. Some of that gas may be arranged to bypass the nitrogen extraction means, for example passing through a separate supply duct, to provide the gas necessary to control CO2 in the perfusate.
The system may further comprise an oxygen control valve arranged to control the flow rate of oxygen from the oxygen concentrator to the oxygenation means.
The system may further comprise oxygen measuring means arranged to measure the oxygen content in the perfusion fluid. The system may further comprise control means arranged to monitor the measured oxygen content. The control means may be arranged to control the oxygen control valve in response to the measured oxygen content. For example it may be arranged to maintain the oxygen content within a target range. The range may be defined by upper and lower limits, or just a lower limit.
The system may include an air control valve arranged to control the flow rate of air from the air supply to the oxygenation means.
The system may further comprise carbon dioxide measuring means arranged to measure the carbon dioxide content in the perfusion fluid. The system may include control means arranged to monitor the measured carbon dioxide content and to control the air control valve in response to the measured carbon dioxide content. For example the control means may be arranged to maintain the carbon dioxide content within a target range. In this case the oxygenation means is arranged both to add oxygen into the fluid and extract carbon dioxide from the fluid, and therefore serves as a gas content adjustment means for adjusting both oxygen and carbon dioxide level. However it will be appreciated that separate adjustment means can be provided, one for oxygen and one for carbon dioxide.
The system may further comprise an analysis duct through which the fluid can flow to bypass the organ. The measuring means may be arranged to measure the fluid in the analysis duct.
The measuring means may be arranged to operate during perfusion of the organ. The control means may be arranged to operate during perfusion of the organ to maintain the target range or ranges during perfusion.
In each case where a target range is referred to above, the range may be defined by upper and lower limits, or just a lower limit, or just an upper limit.
The system may further comprise a user interface arranged to enable a user to input at least one limit of said range, or at least one of said ranges. For example the user interface may be arranged to enable a user to input one or both limits of the target oxygen content, or one or both limits of the target carbon dioxide content.
Preferred embodiments of the present invention will now be described by way of example only with reference to the accompanying drawings.
Referring to
An acities duct 80 is connected at one end to a drainage hole in the bottom of the sling 10 and at the other end to an acities return port 82 in the top of the fluid reservoir 12. An acities pump 84 is provided in the acities duct 80 to pump acities from the sling 10 back up into the reservoir 12.
The perfusion circuit 16 further comprises a portal duct 100, a hepatic artery duct 102 and an inferior vena cava (IVC) duct 104. The portal duct 100 has one end connected to an outlet port 106 in the fluid reservoir and the other end attached to a portal vein connector 108. A flow control valve, in the form of a pinch valve 112 having a variable degree of opening, is provided in the portal duct 100 and is connected to the controller 18. The controller 18 is arranged to vary the degree of opening of the pinch valve 112 so as to control the rate of flow of fluid from the reservoir 12 to the portal vein of a liver. The hepatic artery duct 102 has one end connected to a first outlet port 114 of the oxygenator 14 and the other end attached to a hepatic artery connector 116. A flow sensor 113 is arranged to measure the rate of fluid flow in the portal vein duct 100 and is arranged to output a signal indicative of the flow rate of fluid in the portal vein 100. The output of the flow sensor 113 is connected to the controller 18 which can therefore monitor the flow rate in the portal vein duct 100. The IVC duct 104 has one end attached to a vena cava connector 120 and its other end connected to an inlet port 124 of the oxygenator 14. A pump 123 is provided in the IVC duct 104 having its inlet connected to the vena cava connector 120 and its outlet connected to the inlet port 124 of the oxygenator 14. The pump 123 is arranged to pump fluid from the IVC duct 104 into the oxygenator 124. The pump 123 is a variable speed pump and is connected to, and controlled by, the controller 18. An IVC flow sensor 125 is arranged to measure the rate of fluid flow in the IVC duct 104 and is arranged to output a signal indicative of the flow rate of fluid in the IVC duct 104. The output of the flow sensor 125 is connected to the controller 18 which can therefore monitor the flow rate in the vena cava duct. The controller 18 is also arranged to measure the flow rate in the arterial duct 102 by determining the difference between the flow measured by the flow sensor 125 in the IVC duct 104 and that measured by flow sensor 113 in the portal vein duct 100.
The oxygenator 14 has a second outlet port 140 which is connected by a pressure control duct 142 to a further port 144 in the fluid reservoir 12. A flow control valve, in the form of a pinch valve 146, having a variable degree of opening, is provided in the pressure control duct 142 and is connected to the controller 18 so that the controller can vary the degree of opening of the pinch valve 146 thereby to control the return flow of fluid from the oxygenator 14 to the reservoir 12. This, together with the pump 123, is used to control the pressure of fluid flowing to the organ through the hepatic artery duct 102, as well as the pressure of the fluid in the IVC duct 104 flowing away form the organ.
Referring to
It will be appreciated that other devices can be used for adding oxygen and carbon dioxide into the perfusate. For example a bubbler can be used, instead of the type of oxygenator shown in
Referring back to
A small diameter fluid analysis duct 190 has one end connected to the IVC duct 104, upstream of the pump 123, and in this case downstream of the IVC flow sensor 125, and the other end connected to the pressure control duct 142 so that fluid can flow from the pressure control duct 142 to the IVC duct 104, bypassing the organ. A blood gas analyser (BGA) 192 is arranged to measure various parameters of the fluid flowing through the fluid analysis duct 190. In this embodiment the BGA 192 is arranged to measure the oxygen content and the carbon dioxide content of the fluid flowing through it. Other parameters can also be measured and monitored. The BGA 192 is connected to the controller 18 and arranged to output signals each of which is indicative of the value of one of the parameters it measures, and the controller 18 is arranged to receive those signals so that the parameters can be monitored by the controller 18. The signals therefore include an oxygen level signal, a CO2 level signal, and a glucose level signal in this embodiment.
Referring to
In a modification to the arrangement of
Referring back to
The oxygen level in the perfusate fluid is also controlled by the controller 18 during perfusion. While most of the oxygenated perfusate from the oxygenator outlet 114 flows through the hepatic artery duct 102, a small proportion of it is diverted through the fluid analysis duct 190 and through the BGA 192. The BGA 192 detects the level of oxygen in the perfusate, which is monitored by the controller 18. The controller 18 is arranged to control the pressure and flow rate of oxygen supplied by the oxygen concentrator 200 to the oxygenator by controlling the pump 208 and the two-way valve 210 of the oxygen concentrator 200, so as to control the rate at which perfusate is oxygenated in the oxygenator 100. The controller 18 is arranged to keep the oxygen level of the blood at a predetermined level or within a predetermined range. The controller 18 has a memory in which a target level or range of the oxygen content can be stored and the controller is arranged to compare the measured level with the stored level to determine how the oxygen level needs to be controlled. Typically the complete range will be defined, with upper and lower limits of oxygen content. However the range may be defined only by a lower limit, in which case the controller can be arranged to trigger a process to add oxygen to provide a step increase in oxygen content when the oxygen content falls below that level. The stored target level or range can be selected and altered by means of a user input which in this case is in the form of a graphic user interface (GUI) 17 connected to the controller 18. The GUI 17 is also arranged to display various information including the values of various operating parameters of the system, which in this embodiment include oxygen level, CO2 level, glucose level, temperature, and flow rate of the perfusate.
The carbon dioxide (CO2) level in the perfusate is also monitored and controlled by the controller 18 in a similar way to the oxygen level, except that it is arranged to increase the flow rate of air to reduce the CO2 level, decrease the flow rate of air to increase the CO2 level. The controller 18 is arranged to continuously use the CO2 level signal from the BGA 192 to measure the CO2 level in the perfusate, compare it with target levels stored in memory in the controller 18, and control the air flow control valve 226 to control the flow rate of air into the oxygenator 16. Varying the flow rate of air varies the rate at which CO2 is extracted from the perfusate, so controlling the air flow rate through the oxygenator can be used to control the CO2 level in the perfusate. If the CO2 level is above the target range, then the flow rate of air is increased so as to increase the rate at which CO2 is extracted from the perfusate. If the CO2 level is below the target range, then the air flow rate is decreased to decrease the rate at which CO2 is extracted from the perfusate. The target CO2 level or range can also be set and adjusted by a user by means of the user input 17.
In the embodiment described above, the system is arranged for perfusion of a liver. However other organs such as the kidney can be perfused, and such organs only have one artery to supply blood to the organ and one vein to take blood from the organ. Therefore in another embodiment the system is the same as that described above except that the portal vein duct is completely omitted.
Number | Date | Country | Kind |
---|---|---|---|
1119420.6 | Nov 2011 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/GB2012/052783 | 11/8/2012 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2013/068753 | 5/16/2013 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3772153 | De Roissart | Nov 1973 | A |
4493692 | Reed | Jan 1985 | A |
5157930 | McGhee et al. | Oct 1992 | A |
5462416 | Dennehey et al. | Oct 1995 | A |
5695717 | Polaschegg | Dec 1997 | A |
6582953 | Brasile | Jun 2003 | B2 |
6642045 | Brasile | Nov 2003 | B1 |
6673594 | Owen | Jan 2004 | B1 |
7491261 | Warren | Feb 2009 | B2 |
20040170950 | Prien | Sep 2004 | A1 |
20040235142 | Schein et al. | Nov 2004 | A1 |
20040238444 | Ragusa | Dec 2004 | A1 |
20050221269 | Taylor et al. | Oct 2005 | A1 |
20050255442 | Brassil et al. | Nov 2005 | A1 |
20060148062 | Hassanein et al. | Jul 2006 | A1 |
20060224334 | Zhang et al. | Oct 2006 | A1 |
20070227360 | Atlas | Oct 2007 | A1 |
20070275364 | Hassanein et al. | Nov 2007 | A1 |
20080017194 | Hassanein et al. | Jan 2008 | A1 |
20080032398 | Cannon et al. | Feb 2008 | A1 |
20090197241 | Fishman et al. | Aug 2009 | A1 |
20090197324 | Fishman | Aug 2009 | A1 |
20100028979 | Faulkner et al. | Feb 2010 | A1 |
20100143192 | Myrick et al. | Jun 2010 | A1 |
20100330547 | Tempelman et al. | Dec 2010 | A1 |
20110076666 | Brassil | Mar 2011 | A1 |
20110136096 | Hassanein et al. | Jun 2011 | A1 |
20120178150 | Tempelman et al. | Jul 2012 | A1 |
Number | Date | Country |
---|---|---|
197 02 098 | Jul 1998 | DE |
197 15 152 | Oct 1998 | DE |
100 15 807 | Oct 2001 | DE |
0 109 373 A2 | May 1984 | EP |
1 168 913 | Nov 2005 | EP |
WO 9629865 | Oct 1996 | WO |
WO 02077579 | Oct 2002 | WO |
WO 2004089085 | Oct 2004 | WO |
WO 2006042138 | Apr 2006 | WO |
WO 2006118990 | Nov 2006 | WO |
WO 2007124044 | Nov 2007 | WO |
WO 2008150587 | Dec 2008 | WO |
WO 2009020412 | Feb 2009 | WO |
WO 2012170633 | Dec 2012 | WO |
Entry |
---|
International Search Report and Written Opinion dated Jul. 5, 2013 for PCT/GB2012/052781 filed Nov. 8, 2012. |
International Search Report and Written Opinion dated Mar. 6, 2013 for PCT/GB2012/052783 filed Nov. 8, 2012. |
International Preliminary Report on Patentability dated May 13, 2014 for PCT/GB2012/052783 filed Nov. 8, 2012. |
Search Report Under Section 17 dated Mar. 8, 2012 for GB 1119420.6 filed Nov. 10, 2011. |
International Search Report and Written Opinion dated Jun. 14, 2013 for PCT/GB2012/052782 filed Nov. 8, 2012. |
International Preliminary Report on Patentability dated May 22, 2014 for PCT/GB2012/052782 filed Nov. 8, 2012. |
Search Report Under Section 17 dated Mar. 7, 2012 for GB 1119418.0 filed Nov. 10, 2011. |
Search Report Under Section 17 dated Mar. 7, 2012 for GB 1119419.8 filed Nov. 10, 2011. |
International Preliminary Report on Patentability dated May 22, 2014 for PCT/GB2012/052781 filed Nov. 8, 2012. |
Search Report Under Section 17 dated Mar. 8, 2012 for GB 1119417.2 filed Nov. 10, 2011. |
Examination Report Under Section 18(3) dated Feb. 3, 2017 for GB 1408217.6 filed Nov. 8, 2012. |
Non-final Office Action dated Mar. 11, 2019 for U.S. Appl. No. 15/338,841. |
Number | Date | Country | |
---|---|---|---|
20150004677 A1 | Jan 2015 | US |